RenovoRx (RNXT) Q1 2025 Earnings Call May 15, 2025 04:30 PM ET Speaker0 Good afternoon, everyone, and welcome to the Renovo Rx q one twenty twenty five financial and operational highlights conference call. All participants will be in a listen only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press and then 1 on your touch tone phones. To withdraw your questions, you may press and 2. Please also note today's event is being recorded. At this time, ...

Core Insights - Planet Fitness, Inc. (PLNT) reported lower-than-expected first-quarter 2025 results, with adjusted earnings and revenues missing the Zacks Consensus Estimate, although both metrics increased year-over-year [1][4] - The company is facing macroeconomic volatility, increased costs, and expenses, particularly in SG&A and club operations [1][2] Financial Performance - Adjusted earnings per share (EPS) for Q1 2025 were 59 cents, missing the consensus estimate of 62 cents by 4.8%, while the prior-year quarter reported adjusted EPS of 53 cents [4] - Quarterly revenues were $276.7 million, lagging the consensus mark of $282 million by 1.7%, but rose 11.5% year-over-year due to new club openings and membership growth [4] - Adjusted EBITDA was $117 million, up 10% from $106.3 million reported in the year-ago quarter [5] Segment Performance - Franchise segment revenues rose 10.7% year-over-year to $115.2 million, with adjusted EBITDA of $84.9 million, up from $76.1 million [6] - Corporate-owned clubs generated revenues of $133.7 million, up 9.2% year-over-year, with adjusted EBITDA totaling $45.8 million, an increase from $42.4 million [7] - Equipment segment revenues totaled $27.8 million, up 28.7% year-over-year, with adjusted EBITDA rising to $7.4 million from $4.8 million [8] Cash and Debt Position - As of March 31, 2025, Planet Fitness had cash and cash equivalents of $343.9 million, up from $293.2 million at the end of 2024, while long-term debt decreased slightly to $2.14 billion [9] 2025 Outlook - For 2025, the company expects approximately 130-140 new equipment placements and 160-170 new club openings, with same-club sales growth projected in the 5-6% range [10] - Revenues are anticipated to increase approximately 10% from 2024 levels, with adjusted EBITDA and net income expected to grow around 10% and 8-9%, respectively [11] - Capital expenditures are now projected to increase approximately 20%, a revision from the previously expected 25% increase [12]

Stonegate Capital Partners Updates 1Q25 Report on Gladstone Commercial Corp. (GOOD)May 09, 2025 9:32 AM EDT | Source: Reportable, Inc. Dallas, Texas--(Newsfile Corp. - May 9, 2025) - Gladstone Commercial Corporation. (NASDAQ: GOOD): Stonegate Capital Partners Updates Coverage on Gladstone Commercial Corp. (NASDAQ: GOOD). GOOD reported revenue, FFO per share, and AFFO per share of $37.5M, $0.34, and $0.29, respectively. This compares to our/consensus estimates of $36.8M/$37.3M, $0.34/$0.34, and ...

Independent oil refiner and marketer Marathon Petroleum Corporation (MPC) reported a first-quarter 2025 adjusted loss per share of 24 cents, narrower than the Zacks Consensus Estimate of a loss of 63 cents. This primarily reflects the stronger-than-expected performance of its Refining & Marketing segment. The adjusted EBITDA of the segment totaled $489 million, surpassing the consensus mark of $286 million on the back of lower costs and higher throughput.However, the company’s bottom line fell sharply from ...

Capital Clean Energy Carriers (CCEC) Q1 2025 Earnings Call May 08, 2025 10:00 AM ET Company Participants Brian Gallagher - Executive Vice President of Investor RelationGerasimos Kalogiratos - CEO and DirectorNikos Tripodakis - Chief Commercial OfficerJonathan Chappell - Senior Managing DirectorLiam Burke - Managing DirectorNikos Kalapotharakos - CFOOmar Nokta - Managing DirectorCliment Molins - Head of Shipping Research Conference Call Participants Alexander Bidwell - Associate Analyst Operator Thank you fo ...

Capital Clean Energy Carriers (CCEC) Q1 2025 Earnings Call May 08, 2025 10:00 AM ET Speaker0 Thank you for standing by, and welcome to the Capital Clean Energy Carrier Corp first quarter twenty twenty five financial results conference call. We have with us mister Jerry Collodiarata, chief executive officer, mister Brian Gallagher, executive vice president, investor relations, and mister Nikos Chubodakis, chief commercial officer. At this time, all participants are in a listen only mode. There'll be a presen ...

Core Insights - Crocs reported revenue of $937.33 million for Q1 2025, a slight year-over-year decline of 0.1%, with EPS at $3.00 compared to $3.02 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $909.56 million by 3.05%, and the EPS surpassed the consensus estimate of $2.51 by 19.52% [1] Revenue Breakdown - Crocs Brand revenue was $761.61 million, exceeding the average estimate of $744.37 million, reflecting a year-over-year increase of 2.4% [4] - HEYDUDE Brand revenue was $175.73 million, below the average estimate of $166.55 million, showing a year-over-year decline of 9.8% [4] - Direct-to-Consumer revenue for Crocs Brand was $284.80 million, slightly above the estimate of $279.37 million [4] - HEYDUDE Brand Direct-to-Consumer revenue reached $65.03 million, surpassing the estimate of $61.63 million [4] - Wholesale revenue for Crocs Brand was $476.80 million, exceeding the estimate of $467.14 million [4] - HEYDUDE Brand Wholesale revenue was $110.69 million, above the estimate of $105.40 million [4] Margin Analysis - Non-GAAP Gross Margin for HEYDUDE Brand was 46.6%, lower than the estimated 47.9% [4] - Non-GAAP Gross Margin for Crocs Brand was 60.7%, higher than the estimated 58.3% [4] Stock Performance - Crocs shares returned +1.2% over the past month, underperforming the Zacks S&P 500 composite's +11.3% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]

Core Insights - Springbig has announced the addition of three seasoned executives to its leadership team, reflecting the company's commitment to growth, innovation, and operational excellence as it scales its SaaS platform across North America [1][6]. Leadership Changes - Jaret Christopher has been appointed as the new CEO & President, bringing over 25 years of experience in building high-growth vertical SaaS companies and a proven track record in scaling software businesses [2]. - James Cabral joins as Chief Operating Officer, with extensive experience in leading go-to-market teams and a successful background in both startups and large public companies [3]. - Jason Moos has been appointed as Chief Financial Officer, succeeding Paul Sykes, and has over 20 years of financial and operational leadership experience, including significant achievements in M&A and revenue growth [4]. - David Schachter has been appointed Vice President of Business Development, enhancing Springbig's customer acquisition and partnership strategy with over a decade of experience in CRM and SaaS [5]. Strategic Vision - The new leadership team is expected to accelerate product innovation, scale operations, and deepen relationships with clients and partners in the MarTech ecosystem [6].

Group 1 - The core idea of the report is to provide a practical handbook for omnichannel automation, aimed at helping marketing departments achieve growth certainty in digital marketing [1][5][6] - Marketing automation (MA) integrates various marketing functions into a digital marketing system, enhancing operational efficiency and promoting marketing growth [1][11][12] - MA is distinct from CRM and SCRM, focusing on full-link operations, user interactions, and nurturing [1][15][16] Group 2 - MA enables strategic growth by amplifying and accelerating marketing strategies through multi-touch data acquisition, leading to intelligent and automated operations [2][61] - The report emphasizes the importance of developing a go-to-market (GTM) strategy that aligns with MA for customer insights and marketing growth [2][3] - Companies should select MA products based on their specific needs, considering management strategies, growth goals, and lead operations [2][4] Group 3 - Focussend's advantages include strong delivery technology, content production capabilities, and a modular pricing system that reduces costs [2][5] - The report highlights the challenges faced by marketing departments in a down economy, including reduced budgets and personnel, while still being expected to drive growth [5][6] - The need for a gradual digital marketing development path is emphasized for companies lagging in digital transformation [6][29] Group 4 - The future of marketing automation is expected to integrate natural language generation AI (AIGC), enhancing creativity and reducing production barriers [29][30] - Cross-departmental collaboration between sales and marketing teams is anticipated to improve customer journey management [30][32] - The increasing importance of private domain operations aligns with marketing automation solutions, especially in the context of growing social media usage [31][32] Group 5 - MA is seen as a critical tool for enhancing organizational efficiency, transforming marketing departments from cost centers to customer growth centers [68][69] - The report indicates that effective collaboration between marketing and sales can significantly boost marketing revenue [68][69] - The focus on precision marketing through data-driven strategies is highlighted as a key competitive advantage for businesses [66][67]

Financial Data and Key Metrics Changes - For Q2 of fiscal 2025, total revenue was $124.3 million, a 4.4% increase from $119 million in Q2 of fiscal 2024, primarily driven by an increase in RMS segment revenue [8][25] - Adjusted EBITDA for Q2 was $8 million, or 6.4% of total revenue, compared to $3.1 million, or 2.6% of total revenue in the same quarter last year [27][28] - Consolidated net loss attributable to common shareholders was $14.9 million, or a loss of $0.44 per diluted share, compared to a loss of $48.1 million, or $1.86 per diluted share in Q2 of fiscal 2024 [27] Business Line Data and Key Metrics Changes - RMS segment revenue increased by $6.6 million, or 9.1%, compared to Q2 of fiscal 2024, mainly due to higher NHP volumes sold [25][26] - DSA revenue decreased to $45.3 million from $46.6 million in Q2 of fiscal 2024, primarily due to a decline in general toxicology services revenue [26] - DSA net new orders were $44.5 million, a 27% increase over Q2 of fiscal 2024, with a book to bill ratio of 1.01:1 [26][28] Market Data and Key Metrics Changes - The company noted geopolitical and macroeconomic risks affecting the industry, but expects continued year-over-year revenue and adjusted EBITDA growth for the next two quarters [9][23] - The company has not seen material changes in demand due to current tariffs, although there is some cost inflation linked to tariffs [22][23] Company Strategy and Development Direction - The company is focused on client satisfaction, integration of scientific services, and site optimization plans to improve operational efficiency and margins [7][10] - A revised RMS site optimization plan is expected to yield annual cost savings of $6 million to $7 million, with completion anticipated by March 2026 [11][12] - The company is adapting to FDA announcements regarding drug development and animal testing, positioning itself to leverage new methodologies [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the level of quoting and awards in the DSA segment, expecting improvements in margins starting in Q3 of fiscal 2025 [49][86] - The company is monitoring NIH funding impacts but has not seen significant changes in business yet [52][54] - Management remains confident in the company's ability to navigate geopolitical and macroeconomic uncertainties while creating value for clients and shareholders [23][24] Other Important Information - The company plans to hold an Investor Day on May 29 to further discuss its strategic plan and focus on client excellence [87] - The company has made significant investments in acquisitions and site optimizations to prepare for future growth [7][10] Q&A Session Summary Question: Changes in marketing strategies post-FDA announcement - Management has integrated new services into their discovery sales process and is seeing some growth, though not as rapid as expected [35][36] Question: Focus areas in the revised RMS optimization plan - The revised plan aims to improve efficiencies and reduce costs, with a focus on maximizing existing resources rather than expanding capacity [40][41] Question: Current demand trends and quoting activity - Management reported a positive start to the current quarter, with strong quoting and closing activity [46][49] Question: Impact of NIH funding on customer mix - There has been no dramatic impact from NIH funding yet, with some customers increasing orders while others have reduced them [52][54] Question: DSA margin improvement timeline - Management expects to see benefits from identified margin improvement areas sooner rather than later, with some improvements already noted [66][68]